The Midwest faces some of the highest obesity rates in the country, and New Haven is no exception. With Indiana reporting 36.8% obesity prevalence and 12.4% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to New Haven residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · New Haven is already seeing results
GLP-1 weight-loss treatment available to eligible patients in New Haven, IN. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For New Haven residents, Weight Method makes its compounded Tirzepatide program accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Individual response varies, and your provider sets expectations based on your clinical profile rather than on brand-product trial figures.
Suburban life around New Haven comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide addresses the biology behind weight gain by reducing hunger signals and improving metabolic function, so New Haven area residents can break patterns that willpower alone cannot fix. Weight Method prescribes Tirzepatide virtually, with medication delivered to your door.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Indiana and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.